
Sign up to save your podcasts
Or
Brian Culley, CEO of Lineage Cell Therapeutics, talks about a new approach to treating diseases called whole cell replacement therapy - which replaces damaged cells with new ones. Lineage is focusing this new therapy on dry age-related macular degeneration (AMD), a leading cause of blindness, through their collaboration with Genentech..
4.1
2929 ratings
Brian Culley, CEO of Lineage Cell Therapeutics, talks about a new approach to treating diseases called whole cell replacement therapy - which replaces damaged cells with new ones. Lineage is focusing this new therapy on dry age-related macular degeneration (AMD), a leading cause of blindness, through their collaboration with Genentech..
6,185 Listeners
4,248 Listeners
32,071 Listeners
3,395 Listeners
21,906 Listeners
2,162 Listeners
26,327 Listeners
3,372 Listeners
6,624 Listeners
9,243 Listeners
318 Listeners
30 Listeners
15,371 Listeners
3,303 Listeners
1,170 Listeners